GSK holds scientific symposium for Bonviva

Published: 2006-12-07 06:57:00

Updated: 2006-12-07 06:57:00

GSK said on December 3 that it sponsored its scientific symposium for Bonviva (ibandronate), the first and only once-monthly tablet for the effective treatment of postmenopausal osteoporosis prior to its launching in the first half of next year.

Professor Phillip Shambrook at Sydney University...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK